← All trials
NCT04809389
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 29, 2021
- Primary completion
- Sep 30, 2022
- Completion date
- Sep 30, 2022
- First posted
- Mar 22, 2021
- Last posted
- Sep 27, 2021
- Enrollment
- 115
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The University of Hong KongLead sponsor
- The University of Hong KongOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.